Graduate School, Southern Medical University, Shatai Nan Road 1023, Guangzhou 510515, Guangdong Province, China; Department of Endocrinology, Wuhan General Hospital of Chinese People's Liberation Army, Wuluo Road 627, Wuhan 430070, Hubei Province, China.
Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Vascul Pharmacol. 2019 Apr;115:55-63. doi: 10.1016/j.vph.2018.11.003. Epub 2018 Nov 14.
Perivascular adipose tissue (PVAT) regulates vascular function in a paracrine manner and the vasodilatory effect of PVAT on vessels is completely abolished in obesity. In addition, autophagy is required for maintaining biological function of PVAT and has been shown to be inhibited in obesity. The aim of this study was to explore whether alogliptin improves endothelial function by promoting autophagy in PVAT in obese mice.
C57BL/6 mice were maintained on high fat diet with or without alogliptin intervention for 3 months. Vasorelaxation function of thoracic aorta with or without PVAT was determined. Autophagy related protein level of p62 and LC3B, along with phosphorylated mTOR (p-mTOR) were evaluated. In addition, the effects of alogliptin on autophagy were also investigated in cultured adipocytes.
The presence of PVAT significantly impaired endothelium-dependent vasodilation in obese mice and alogliptin intervention corrected this defect. Autophagy in PVAT was decreased in obese mice and alogliptin intervention activated autophagy. Activating autophagy in PVAT improved endothelium-dependent vasodilation while blocking it in PVAT impaired vasodilation function. Further, addition of glucagon-like peptide-1 (GLP-1) but not alogliptin alone activated autophagy. Moreover, GLP-1 and alogliptin co-treatment did not show additive effect on activating autophagy.
These results revealed that promoting autophagy in PVAT improved endothelial function in response to alogliptin intervention. Additionally, the beneficial effect of alogliptin intervention on PVAT was GLP-1 dependent.
血管周脂肪组织(PVAT)通过旁分泌方式调节血管功能,而肥胖会完全消除 PVAT 对血管的舒张作用。此外,自噬对于维持 PVAT 的生物学功能是必需的,并且已经表明在肥胖中受到抑制。本研究旨在探讨阿格列汀是否通过促进肥胖小鼠 PVAT 中的自噬来改善内皮功能。
3 个月内,C57BL/6 小鼠维持高脂肪饮食或同时给予阿格列汀干预。测定有无 PVAT 存在时胸主动脉的血管舒张功能。评估 p62 和 LC3B 相关自噬蛋白水平以及磷酸化 mTOR(p-mTOR)。此外,还研究了阿格列汀对培养脂肪细胞中自噬的影响。
存在 PVAT 会显著损害肥胖小鼠的内皮依赖性血管舒张,而阿格列汀干预纠正了这一缺陷。肥胖小鼠的 PVAT 中自噬减少,而阿格列汀干预激活了自噬。激活 PVAT 中的自噬可改善内皮依赖性血管舒张,而阻断 PVAT 中的自噬则损害血管舒张功能。此外,添加胰高血糖素样肽-1(GLP-1)而不是单独添加阿格列汀可激活自噬。此外,GLP-1 和阿格列汀联合治疗对激活自噬没有相加作用。
这些结果表明,激活 PVAT 中的自噬可改善阿格列汀干预后的内皮功能。此外,阿格列汀干预对 PVAT 的有益作用依赖于 GLP-1。